Indeed, the IL-1β secreted in the tumor microenvironment induces the secretion of IL-17 through its effect on CD4 T cells, by driving the differentiation and expansion of Th17 cells, which promote angiogenesis and tumor growth via the STAT3 signaling pathway [69,80]. Here, CD4 is linked to neoplasm.